In Vivo Drug Articles & Analysis
12 news found
“Our analysis and testing services will support pharmaceutical companies at every step and phase of the drug development lifecycle, making sure the entire drug development process complies with the latest regulatory standards and ...
In the process of drug development, the evaluation of drug effectiveness is one of the keys to determining whether prodrugs can sufficiently reach the market stage. ...
Pronalyse is a new division of Creative Proteomics, which is an integrated CRO company with rich experience in providing drug development services. Building on its years of experience, Creative Proteomics Pronalyse announces the launch of its metabolite identification services of biopharmaceuticals for an accurate and efficient analysis of the metabolism for your biological ...
Together with state-of-the-art analytical instruments, the company is capable of conducting analytical process development and validation services for drug formulation projects. Recently, CD Formulation announced that it now offers the disintegration test, which is an important quality control (QC) test in drug analysis ever since its inception in the 1930s. ...
The study, titled “Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Haematological Cancers and Identifies Exceptional Responders,” illustrates the potential real-world impact of using Exscientia’s AI-supported precision medicine platform (referred to in the study as single-cell functional precision medicine or scFPM) to propose which therapy would ...
There is an intense need for more accurate screening methods during preclinical studies using in vitro assays that more closely mimic in vivo conditions. Currently, only 12% of drugs that begin phase 1 clinical trials move on to eventually receive FDA approval. ...
Study Results The study evaluated the in vitro drug release and in vivo pharmacokinetics of novel XTreo™ MF matrices in a rabbit dorsal maxillary osteotomy model. ...
Find out how to use Inovotion’s cutting-edge in vivo technology in your future projects, presented by our experts. #1 How to optimize in vivo preclinical evaluation of synergistic immuni-oncology drug candidate. Speaker:Yan WANG, PhD, MD, R&D Dpt #2 Preclinical evaluation of antimetastatic drug candidate using a ...
Through a new distribution agreement, Lonza will supply a selection of cells to be prequalified for use in CN Bio’s innovative PhysioMimixTM Organ-On-a-Chip (OOC) range of Single- and Multi-Organ Microphysiological Systems (MPS) The companies share a common goal of developing and supplying advanced cell models that better reflect an in vivo environment to improve ...
CIS Pharma successfully completed the biodistribution study with its polymer carrier technology applied to an antibody radionuclide conjugate (ARC). The conjugate was tested in a SKOvip mouse model, an aggressive form of ovarian cancer. The ARC tested comprised Trastuzumab as a model antibody to which two polymer carriers were conjugated that contained several chelators for the immobilization of ...
The work will be done in collaboration with Dr Frédéric Calon from CHU du Québec – Université Laval, an expert in in vivo analysis of drug availability, toxicity and pharmacokinetics. This technology overcomes many of the barriers that in the past have precluded intracellular delivery of antibodies and peptides, thereby ...
The companies, funded by NSF and focused on drug discovery, diagnostics and other platform technologies, will participate in a dedicated track of company presentations. ...